Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model

Stem Cells and Development

Volumn 21, Issue 14, 2012, Pages 2642-2655

  Jeon, Kilsoo ^a   Lim, Hyejin ^a   Kim, Jung Hyun ^a   Van Thuan, Nguyen ^a   Park, Seung Hwa ^b   Lim, Yu Mi ^c   Choi, Hye Yeon ^a   Lee, Eung Ryoung ^a   Kim, Jin Hoi ^a   Lee, Myung Shik ^c   Cho, Ssang Goo ^a  

^a Konkuk University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA TUBULIN; BONE MORPHOGENETIC PROTEIN 4; CELL MARKER; FIBROBLAST GROWTH FACTOR 4; GLUCOSE; INSULIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; POTASSIUM CHLORIDE; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL THERAPY; CHIMERA; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENGRAFTMENT; EPITHELIUM CELL; FEMALE; FIBROBLAST; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY TRANSPLANTATION; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TERATOMA;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELL DIFFERENTIATION; CHIMERA; DIABETES MELLITUS, EXPERIMENTAL; EMBRYONIC STEM CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GERM LAYERS; GLUCOSE; HYPERGLYCEMIA; INDUCED PLURIPOTENT STEM CELLS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, INBRED NOD; MICE, SCID; POTASSIUM CHLORIDE; STREPTOZOCIN; TERATOMA;

ANIMALIA; MUS;

EID: 84866239774     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0665     Document Type: Article

References (55)

1. Deruytter N, O Boulard and HJ Garchon. (2004). Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. Diabetes 53:3323-3327. (Pubitemid 39564511)
2. -(1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197.
3. Naftanel MA and DM Harlan. (2004). Pancreatic islet transplantation. PLoS Med 1:e58; quiz e75.
4. Lakey JR, M Mirbolooki and AM Shapiro. (2006). Current status of clinical islet cell transplantation. Methods Mol Biol 333:47-104.
5. Robertson RP, TV Holohan and S Genuth. (1998). Therapeutic controversy: pancreas transplantation for type I diabetes. J Clin Endocrinol Metab 83:1868-1874. (Pubitemid 28496308)
6. Shapiro AM, JR Lakey, EA Ryan, GS Korbutt, E Toth, GL Warnock, NM Kneteman and RV Rajotte. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238. (Pubitemid 30490390)
7. Hering BJ, M Wijkstrom, ML Graham, M Hardstedt, TC Aasheim, T Jie, JD Ansite, M Nakano, J Cheng, et al. (2006). Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12:301-303. (Pubitemid 43355076)
8. Hecht G, S Eventov-Friedman, C Rosen, E Shezen, D Tchorsh, A Aronovich, E Freud, H Golan, R El-Hasid, et al. (2009). Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A 106:8659-8664.
9. D'Amour KA, AG Bang, S Eliazer, OG Kelly, AD Agulnick, NG Smart, MA Moorman, E Kroon, MK Carpenter and EE Baetge. (2006). Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24:1392-1401. (Pubitemid 44722103)
10. Kroon E, LA Martinson, K Kadoya, AG Bang, OG Kelly, S Eliazer, H Young, M Richardson, NG Smart, et al. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443-452. (Pubitemid 351501814)
11. Tyndall A, UA Walker, A Cope, F Dazzi, C De Bari, W Fibbe, S Guiducci, S Jones, C Jorgensen, et al. (2007). Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 9:301.
12. Morigi M, B Imberti, C Zoja, D Corna, S Tomasoni, M Abbate, D Rottoli, S Angioletti, A Benigni, et al. (2004). Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794-1804. (Pubitemid 38822058)
13. Duffield JS, KM Park, LL Hsiao, VR Kelley, DT Scadden, T Ichimura and JV Bonventre. (2005). Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755. (Pubitemid 40979713)
14. Abdi R, P Fiorina, CN Adra, M Atkinson and MH Sayegh. (2008). Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 57:1759-1767.
15. Camp DM, DA Loeffler, DM Farrah, JN Borneman and PA LeWitt. (2009). Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease. J Neuroinflammation 6:17.
16. Colman A and O Dreesen. (2009). Pluripotent stem cells and disease modeling. Cell Stem Cell 5:244-247.
17. Lee CH, EY Kim, K Jeon, JC Tae, KS Lee, YO Kim, MY Jeong, CW Yun, DK Jeong, et al. (2008). Simple, efficient, and reproducible gene transfection of mouse embryonic stem cells by magnetofection. Stem Cells Dev 17:133-141. (Pubitemid 351271607)
18. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
19. Rubin LL. (2008). Stem cells and drug discovery: the beginning of a new era? Cell 132:549-552. (Pubitemid 351253700)
20. Anderson MS and JA Bluestone. (2005). The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447-485. (Pubitemid 40563177)
21. Wicker LS, J Clark, HI Fraser, VE Garner, A Gonzalez-Munoz, B Healy, S Howlett, K Hunter, D Rainbow, et al. (2005). Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 25 Suppl:29-33. (Pubitemid 41728041)
22. Atkinson MA and EH Leiter. (1999). The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601-604. (Pubitemid 29289413)
23. Delovitch TL and B Singh. (1997). The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738. (Pubitemid 28064887)
24. Lakey JR, B Singh, GL Warnock and RV Rajotte. (1994). BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. Transplantation 57:1213-1217. (Pubitemid 24139644)
25. Chatenoud L, J Primo and JF Bach. (1997). CD3 antibodyinduced dominant self tolerance in overtly diabetic NOD mice. J Immunol 158:2947-2954. (Pubitemid 127470558)
26. Wang T, B Singh, GL Warnock and RV Rajotte. (1992). Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41:114-117.
27. Ryu S, S Kodama, K Ryu, DA Schoenfeld and DL Faustman. (2001). Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest 108:63-72. (Pubitemid 32634923)
28. Rabinovitch A, WL Suarez-Pinzon, AM Shapiro, RV Rajotte and R Power. (2002). Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes 51:638-645. (Pubitemid 34760170)
29. Wu Q, B Salomon, M Chen, Y Wang, LM Hoffman, JA Bluestone and YX Fu. (2001). Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 193:1327-1332. (Pubitemid 32524783)
30. Gregori S, N Giarratana, S Smiroldo, M Uskokovic and L Adorini. (2002). A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374. (Pubitemid 34826601)
31. Bertry-Coussot L, B Lucas, C Danel, L Halbwachs-Mecarelli, JF Bach, L Chatenoud and P Lemarchand. (2002). Long-term reversal of established autoimmunity upon transient blockade of the LFA-1/intercellular adhesion molecule-1 pathway. J Immunol 168:3641-3648. (Pubitemid 34250436)
32. Rayat GR, B Singh, GS Korbutt and RV Rajotte. (2000). Single injection of insulin delays the recurrence of diabetes in syngeneic islet-transplanted diabetic NOD mice. Transplantation 70:976-979.
33. Sandberg JO, DL Eizirik and S Sandler. (1997). IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic nonobese diabetic (NOD) mice. Clin Exp Immunol 108:314-317. (Pubitemid 27223472)
34. Parrinello S, E Samper, A Krtolica, J Goldstein, S Melov and J Campisi. (2003). Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747. (Pubitemid 36986782)
35. Bolton WE, SP Terrell, KL Andrews and AE Boyd. (1982). Preparation of primary monolayer cultures of mouse pancreatic epithelial cells. Methods Cell Sci 7:39-42. (Pubitemid 13065871)
36. Lee CH, JH Kim, HJ Lee, K Jeon, H Lim, H Choi, ER Lee, SH Park, JY Park, et al. (2011). The generation of iPS cells using non-viral magnetic nanoparticle based transfection. Biomaterials 32:6683-6691.
37. Yamada T, M Yoshikawa, S Kanda, Y Kato, Y Nakajima, S Ishizaka and Y Tsunoda. (2002). In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 20:146-154. (Pubitemid 34297262)
38. Niwa H, J Miyazaki and AG Smith. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376. (Pubitemid 30187435)
39. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. (Pubitemid 34164012)
40. Maehr R, S Chen, M Snitow, T Ludwig, L Yagasaki, R Goland, RL Leibel and DA Melton. (2009). Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 106:15768-15773.
41. Zhang D, W Jiang, M Liu, X Sui, X Yin, S Chen, Y Shi and H Deng. (2009). Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 19:429-438.
42. Szot GL, P Koudria and JA Bluestone. (2007). Murine pancreatic islet isolation. J Vis Exp 255.
43. Kim YH, S Kim, KA Kim, H Yagita, N Kayagaki, KW Kim and MS Lee. (1999). Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455-465. (Pubitemid 29078506)
44. Hanna J, S Markoulaki, M Mitalipova, AW Cheng, JP Cassady, J Staerk, BW Carey, CJ Lengner, R Foreman, et al. (2009). Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4:513-524.
45. Teitelman G, S Alpert, JM Polak, A Martinez and D Hanahan. (1993). Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. Development 118:1031-1039. (Pubitemid 23252394)
46. Hayden EC. (2011). Stem cells: the growing pains of pluripotency. Nature 473:272-274.
47. Shultz LD, F Ishikawa and DL Greiner. (2007). Humanized mice in translational biomedical research. Nat Rev Immunol 7:118-130. (Pubitemid 46174859)
48. Brook FA, EP Evans, CJ Lord, PA Lyons, DB Rainbow, SK Howlett, LS Wicker, JA Todd and RL Gardner. (2003). The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome. Diabetes 52:205-208. (Pubitemid 36042128)
49. Theunissen TW, AL van Oosten, G Castelo-Branco, J Hall, A Smith and JC Silva. (2011). Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol 21:65-71.
50. Polo JM, S Liu, ME Figueroa, W Kulalert, S Eminli, KY Tan, E Apostolou, M Stadtfeld, Y Li, et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28:848-855.
51. Kim K, A Doi, B Wen, K Ng, R Zhao, P Cahan, J Kim, MJ Aryee, H Ji, et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290.
52. Bar-Nur O, HA Russ, S Efrat and N Benvenisty. (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 9:17-23.
53. Alyanakian MA, S You, D Damotte, C Gouarin, A Esling, C Garcia, S Havouis, L Chatenoud and JF Bach. (2003). Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci U S A 100:15806-15811. (Pubitemid 38021071)
54. Wu O, GP Chen, H Chen, XP Li, JH Xu, SS Zhao, J Sheng, JB Feng, J Cai, et al. (2009). The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. Immunobiology 214:392-402.
55. Zhao T, ZN Zhang, Z Rong and Y Xu. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.